Chimeric bispecific OC/TR monoclonal antibody mediates lysis of tumor cells expressing the folate-binding protein (MOv18) and displays decreased immunogenicity in patients

RM Luiten, SO Warnaar, D Sanborn, CHJM Lamers, RLH (Reinder) Bolhuis, SV Litvinov, VR Zurawski Jr., LR Coney

Research output: Contribution to journalArticleAcademicpeer-review

24 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)496-504
Number of pages9
JournalJournal of Immunotherapy
Issue number6
Publication statusPublished - 1997

Research programs

  • EMC 04-01-DD-12-01

Cite this